Human medicines European public assessment report (EPAR): Cometriq, cabozantinib, Date of authorisation: 21/03/2014, Revision: 33, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 24 September 2026 - 10:35

Human medicines European public assessment report (EPAR): Cometriq, cabozantinib, Date of authorisation: 21/03/2014, Revision: 33, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/cometriq

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters